Intended for healthcare professionals


Details of HPV immunisation need not delay decision

BMJ 2005; 331 doi: (Published 03 November 2005) Cite this as: BMJ 2005;331:1081
  1. Adam Finn, David Baum professor of paediatrics (
  1. Institute of Child Life and Health, Department of Clinical Sciences at South Bristol, University of Bristol, Bristol BS2 8AE

    EDITOR—Lowndes and Gill are upbeat in their appraisal of the future for primary prevention of cervical cancer by immunisation.1 But they then deliver a long list of questions that they suggest should be answered before starting human papillomavirus (HPV) vaccination. For most of their questions, this timing is not supported by recent historical precedent.

    Without doubt …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription